Publikationer / Publications

COVID-19 Immunity studies

Mangsbo SM,  Havervall S,  Laurén I,  Lindsay R,  Jernbom Falk A,  Marking U,  Lord M,  Buggert M,  Dönnes P,  Christoffersson G,  Nilsson P,  Hober S,  Phillipson M,  Klingström J,  Thålin C. An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses. PloS one 2021 16;9 e0258041-

http://www.ncbi.nlm.nih.gov/pubmed/34591918

Havervall S,  Marking U,  Greilert-Norin N,  Ng H,  Gordon M,  Salomonsson AC,  Hellström C,  Pin E,  Blom K,  Mangsbo S,  Phillipson M,  Klingström J,  Hober S,  Nilsson P,  Åberg M,  Thålin C. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. EBioMedicine 2021 70; 103523-

http://www.ncbi.nlm.nih.gov/pubmed/34391088

Havervall S,  Ng H,  Falk AJ,  Greilert-Norin N,  Manberg A,  Marking U,  Lauren I,  Gabrielsson L,  Salomonsson AC,  Aguilera K,  Kihlgren M,  Mansson M,  Rosell A,  Hellstrom C,  Andersson E,  Olofsson J,  Skoglund L,  Yousef J,  Pin E,  Lord M,  Aberg M,  Hedhammar M,  Tegel H,  Donnes P,  Phillipson M,  Nilsson P,  Klingstrom J,  Mangsbo S,  Hober S,  Thalin C. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. JOURNAL OF INTERNAL MEDICINE 2021 ;

http://www.ncbi.nlm.nih.gov/pubmed/34459525

Havervall S, Rosell A,  Phillipson M,  Mangsbo SM,  Nilsson P,  Hober S,  Thalin C. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2021 325;19 2015-2016

http://www.ncbi.nlm.nih.gov/pubmed/33825846

Rudberg AS,  Havervall S,  Månberg A,  Jernbom Falk A,  Aguilera K,  Ng H,  Gabrielsson L,  Salomonsson AC,  Hanke L,  Murrell B,  McInerney G,  Olofsson J,  Andersson E,  Hellström C,  Bayati S,  Bergström S,  Pin E,  Sjöberg R,  Tegel H,  Hedhammar M,  Phillipson M,  Nilsson P,  Hober S,  Thålin C. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nature communications 2020 11;1 5064-

http://www.ncbi.nlm.nih.gov/pubmed/33033249

COVID-19 Biomarker studies

Ng H,  Havervall S,  Rosell A,  Aguilera K,  Parv K,  von Meijenfeldt FA,  Lisman T,  Mackman N,  Thålin C,  Phillipson M. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Arteriosclerosis, thrombosis, and vascular biology 2021 41;2 988-994

http://www.ncbi.nlm.nih.gov/pubmed/33267662

von Meijenfeldt FA,  Havervall S,  Adelmeijer J,  Lundström A,  Magnusson M,  Mackman N,  Thalin C,  Lisman T. COVID-19 is Associated with an Acquired Factor XIII Deficiency. Thrombosis and haemostasis 2021 ;

http://www.ncbi.nlm.nih.gov/pubmed/33742434

von Meijenfeldt FA,  Havervall S,  Adelmeijer J,  Lundström A,  Magnusson M,  Mackman N,  Thalin C,  Lisman T. Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality. American journal of hematology 2021 96;4 E98-E100

http://www.ncbi.nlm.nih.gov/pubmed/33393103

Rosell A,  Havervall S,  von Meijenfeldt F,  Hisada Y,  Aguilera K,  Grover SP,  Lisman T,  Mackman N,  Thålin C. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arteriosclerosis, thrombosis, and vascular biology 2021 41;2 878-882

http://www.ncbi.nlm.nih.gov/pubmed/33267656

von Meijenfeldt FA,  Havervall S,  Adelmeijer J,  Lundström A,  Rudberg AS,  Magnusson M,  Mackman N,  Thalin C,  Lisman T. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Research and practice in thrombosis and haemostasis 2021 5;1 132-141

http://www.ncbi.nlm.nih.gov/pubmed/33537537

Mackman N,  Hisada Y,  Grover SP,  Rosell A,  Havervall S,  von Meijenfeldt F,  Aguilera K,  Lisman T,  Thålin C. Response by Mackman et al to Letter Regarding Article, ”Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report”. Arteriosclerosis, thrombosis, and vascular biology 2021 41;6 e381-e382

http://www.ncbi.nlm.nih.gov/pubmed/34038165

Lundström A,  Ziegler L,  Havervall S,  Rudberg AS,  von Meijenfeldt F,  Lisman T,  Mackman N,  Sandén P,  Thålin C. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers. Journal of medical virology 2021 93;10 5908-5916

http://www.ncbi.nlm.nih.gov/pubmed/34138483

von Meijenfeldt FA,  Havervall S,  Adelmeijer J,  Lundström A,  Magnusson M,  Mackman N,  Thalin C,  Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood advances 2021 5;3 756-759

http://www.ncbi.nlm.nih.gov/pubmed/33560386

%d bloggare gillar detta: